Original Source(s)
Related Content
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
FDA Approves Expanded Liquid Biopsy Panel
Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.
May 20, 2026
-
2 min
First HIV-Positive-to-HIV-Positive Lung Transplant Reported
The procedure was performed under a HOPE Act research protocol at an NYU Langone Health center the institution said is among the limited number of US transplant centers equipped and approved to perform HOPE lung transplants.
June 19, 2026
-
3 min
